64 related articles for article (PubMed ID: 19464057)
1. A high-throughput candidate gene mutation screen in lymphoproliferative and myeloproliferative neoplasias.
Kreil S; Hochhaus A; Cross NC; Chase A
Leuk Res; 2009 Sep; 33(9):e168-9. PubMed ID: 19464057
[No Abstract] [Full Text] [Related]
2. [New insight into myelodysplastic syndromes and related myeloid disorders].
Ogawa S
Rinsho Ketsueki; 2013 Jun; 54(6):533-7. PubMed ID: 23823091
[No Abstract] [Full Text] [Related]
3. New molecular insights in myelodysplastic and myeloproliferative disorders.
Emanuel PD
Clin Adv Hematol Oncol; 2005 Jun; 3(6):459-60. PubMed ID: 16167021
[No Abstract] [Full Text] [Related]
4. Mutant molecules of interest in myeloproliferative neoplasms: introduction.
Tefferi A
Acta Haematol; 2008; 119(4):192-3. PubMed ID: 18566535
[No Abstract] [Full Text] [Related]
5. Acquired mutation the key to MPDs.
Everington T
Practitioner; 2007 Jan; 251(1690):30, 32, 35. PubMed ID: 17290854
[No Abstract] [Full Text] [Related]
6. Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders.
Musolino C; Allegra A; Penna G; Centorrino R; Cuzzola M; D'Angelo A; Iacopino P; Alonci A
Acta Haematol; 2009; 122(1):46-9. PubMed ID: 19816006
[TBL] [Abstract][Full Text] [Related]
7. [Genomic abnormalities and pathophysiology in myelodysplastic syndrome].
Chiba S
Rinsho Ketsueki; 2013 Oct; 54(10):1687-96. PubMed ID: 24064818
[No Abstract] [Full Text] [Related]
8. Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders.
Cerri M; Capello D; Muti G; Rambaldi A; Paulli M; Gloghini A; Berra E; Deambrogi C; Rossi D; Franceschetti S; Conconi A; Morra E; Pasqualucci L; Carbone A; Gaidano G
Br J Haematol; 2004 Nov; 127(3):362-4. PubMed ID: 15491294
[No Abstract] [Full Text] [Related]
9. Mutation analysis of the HAX1 gene in childhood myelodysplastic syndrome.
Steinemann D; Praulich I; Otto N; Göhring G; Niemeyer CM; Schlegelberger B
Br J Haematol; 2009 May; 145(4):533-4. PubMed ID: 19298594
[No Abstract] [Full Text] [Related]
10. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
11. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.
Eisenmann KM; Dykema KJ; Matheson SF; Kent NF; DeWard AD; West RA; Tibes R; Furge KA; Alberts AS
Oncogene; 2009 Oct; 28(39):3429-41. PubMed ID: 19597464
[TBL] [Abstract][Full Text] [Related]
12. [FOXP1 in B-lymphoproliferative diseases].
Mara D
Lijec Vjesn; 2007 May; 129 Suppl 3():43. PubMed ID: 18959064
[No Abstract] [Full Text] [Related]
13. Myelodysplastic/Myeloproliferative disorder with severe leukocytosis: a case report.
Oluwole O; Awujo A; Ivonye C; Sanders L
Am J Clin Oncol; 2009 Jun; 32(3):326-7. PubMed ID: 19887993
[No Abstract] [Full Text] [Related]
14. Lymphoproliferative disorders.
Young GA
Pathology; 2005 Dec; 37(6):407-8. PubMed ID: 16373223
[No Abstract] [Full Text] [Related]
15. Good and bad IRF-1: role in tumor suppression versus autoimmune disease.
Liebermann DA; Hoffman B
Leuk Res; 2009 Oct; 33(10):1301-2. PubMed ID: 19439353
[No Abstract] [Full Text] [Related]
16. [Myelodysplastic syndromes].
Matsuda A
Rinsho Ketsueki; 2009 Mar; 50(3):147-53. PubMed ID: 19352080
[No Abstract] [Full Text] [Related]
17. Isolated deletion of 6q in a patient with myelodysplastic syndrome.
Gozzetti A; Crupi R; Defina M; Bocchia M; Raspadori D; Lauria F
Cancer Genet Cytogenet; 2009 Jul; 192(1):51. PubMed ID: 19480939
[No Abstract] [Full Text] [Related]
18. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.
Bacher U; Haferlach T; Kern W; Weiss T; Schnittger S; Haferlach C
Cancer; 2009 Oct; 115(19):4524-32. PubMed ID: 19569249
[TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics and LGI1 gene mutation analysis on an autosomal dominant lateral temporal lobe epilepsy].
Xi ZQ; Wang XF; Lü Y; Wang L; Xiao F; Guan LF
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):195-7. PubMed ID: 19537038
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnosis of myeloproliferative neoplasms.
Patnaik MM; Tefferi A
Expert Rev Mol Diagn; 2009 Jul; 9(5):481-92. PubMed ID: 19580432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
